Risk of Falls With Newer Antiandrogens for Prostate Cancer
Second-generation antiandrogens for prostate cancer carry a substantial risk of cognitive problems and fatigue, and they increase the risk of falls by 87%, warn researchers.
Medscape Medical News
source https://www.medscape.com/viewarticle/992870?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/992870?src=rss
Comments
Post a Comment